Latest filing published 01 Apr 2024 for Gain Therapeutics, Inc., €107k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -51.4%Entry US$3.89 · Close at T+365 US$1.89
- -6.1%Entry US$17,237.50 · Close at T+365 US$16,187.50
- +8.6%Entry US$15,225.00 · Close at T+365 US$16,537.50
- +8.6%Entry US$15,225.00 · Close at T+365 US$16,537.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Scott Riley: trading record in brief
Jeffrey Scott Riley has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Theriva Biologics, Inc. and Gain Therapeutics, Inc. Between 2 January 2013 and 28 March 2024, the trades on record add up to 6 filings.
No open-market sale appears; the market trades are 6 purchases worth €117k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2024 alone, the filings show 1 purchase and no sales.
The median purchase comes to €3,118. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -16.3%. These figures describe past trades and do not predict future prices.
The record was last updated on 1 April 2024 with an open-market purchase (€107k) in Gain Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Scott Riley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$3.859100.0% of flowCommon StockSEC:0001493152-24-012340:0Canonical exit: 26 Jun 2024 (T+90)
- 5 shares@ US$1.71Common StockSEC:0001144204-13-001056:0Canonical exit: 7 Apr 2013 (T+90)
- 2,895 shares@ US$0.172Common StockSEC:0001144204-13-001056:1Canonical exit: 7 Apr 2013 (T+90)
- 2,000 shares@ US$1.71Common StockSEC:0001144204-13-000800:0Canonical exit: 3 Apr 2013 (T+90)
- 2,700 shares@ US$1.78Common StockSEC:0001144204-13-000459:0Canonical exit: 2 Apr 2013 (T+90)
- 2,800 shares@ US$1.75Common StockSEC:0001144204-13-000459:1Canonical exit: 3 Apr 2013 (T+90)
6 of 6 declarations